Prescription Drug Marketing Act Re-Opening Sought By Rep. Emerson
Executive Summary
FDA needs to reopen its final rule implementing the Prescription Drug Marketing Act because it places an undue burden on small drug distributors, Rep. Emerson (R-Mo.) told the agency in a March 3 letter.